BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,975,286
- Total 13F shares
- 177,743,163
- Share change
- -3,641,805
- Total reported value
- $13,419,458,431
- Put/Call ratio
- 150%
- Price per share
- $75.51
- Number of holders
- 513
- Value change
- -$323,613,922
- Number of buys
- 241
- Number of sells
- 256
Quarterly Holders Quick Answers
What is CUSIP 09061G101?
CUSIP 09061G101 identifies BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09061G101:
Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
|
Company |
11%
|
22,078,957
|
$1,936,094,000 | — | 31 Dec 2020 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
9.4%
|
18,147,961
|
$1,591,395,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.5%
|
16,369,689
|
$1,435,458,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.6%
|
14,714,160
|
$1,290,284,000 | — | 31 Dec 2020 | |
| DODGE & COX |
13F
|
Company |
5.1%
|
9,796,924
|
$859,092,000 | — | 31 Dec 2020 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.9%
|
7,589,294
|
$665,505,000 | — | 31 Dec 2020 | |
| Clearbridge Investments, LLC |
13F
|
Company |
3.1%
|
6,022,412
|
$528,105,000 | — | 31 Dec 2020 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.9%
|
5,686,942
|
$498,682,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
4,959,779
|
$434,923,000 | — | 31 Dec 2020 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
2.3%
|
4,360,295
|
$382,201,000 | — | 31 Dec 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.6%
|
2,995,270
|
$262,655,000 | — | 31 Dec 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.3%
|
2,482,081
|
$217,654,000 | — | 31 Dec 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.3%
|
2,462,265
|
$215,916,017 | — | 31 Dec 2020 | |
| Palo Alto Investors LP |
13F
|
Company |
1.1%
|
2,155,050
|
$188,976,000 | — | 31 Dec 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
2,064,582
|
$181,043,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
2,057,141
|
$180,151,000 | — | 31 Dec 2020 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.98%
|
1,900,668
|
$166,670,000 | — | 31 Dec 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.94%
|
1,812,284
|
$158,920,000 | — | 31 Dec 2020 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.86%
|
1,650,000
|
$144,689,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.83%
|
1,605,970
|
$140,827,000 | — | 31 Dec 2020 | |
| PARNASSUS INVESTMENTS, LLC |
13F
|
Company |
0.79%
|
1,518,951
|
$133,197,000 | — | 31 Dec 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.77%
|
1,483,988
|
$130,132,000 | — | 31 Dec 2020 | |
| NORGES BANK |
13F
|
Company |
0.75%
|
1,449,496
|
$127,106,000 | — | 31 Dec 2020 | |
| NATIXIS |
13F
|
Company |
0.74%
|
1,422,010
|
$124,696,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.61%
|
1,184,564
|
$103,876,000 | — | 31 Dec 2020 | |
| Legal & General Group Plc |
13F
|
Company |
0.56%
|
1,088,094
|
$95,415,000 | — | 31 Dec 2020 | |
| Manning & Napier Group, LLC |
13F
|
Company |
0.56%
|
1,083,360
|
$94,999,000 | — | 31 Dec 2020 | |
| CARILLON TOWER ADVISERS, INC. |
13F
|
Company |
0.57%
|
1,090,391
|
$94,801,000 | — | 31 Dec 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.55%
|
1,058,375
|
$92,809,000 | — | 31 Dec 2020 | |
| Avidity Partners Management LP |
13F
|
Company |
0.51%
|
992,900
|
$87,067,000 | — | 31 Dec 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.48%
|
935,672
|
$82,049,000 | — | 31 Dec 2020 | |
| Davide Leone & Partners Investment Co Ltd. |
13F
|
Company |
0.47%
|
904,405
|
$79,307,000 | — | 31 Dec 2020 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.46%
|
880,336
|
$77,195,000 | — | 31 Dec 2020 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.44%
|
851,872
|
$74,701,000 | — | 31 Dec 2020 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.43%
|
830,375
|
$72,816,000 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.39%
|
750,514
|
$65,812,000 | — | 31 Dec 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.39%
|
745,456
|
$65,369,000 | — | 31 Dec 2020 | |
| Fiera Capital Corp |
13F
|
Company |
0.37%
|
706,972
|
$61,994,000 | — | 31 Dec 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.36%
|
694,230
|
$60,878,000 | — | 31 Dec 2020 | |
| TCW GROUP INC |
13F
|
Company |
0.36%
|
686,015
|
$60,157,000 | — | 31 Dec 2020 | |
| Swiss National Bank |
13F
|
Company |
0.36%
|
685,132
|
$60,079,000 | — | 31 Dec 2020 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.35%
|
676,981
|
$59,364,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.34%
|
660,299
|
$57,903,000 | — | 31 Dec 2020 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.33%
|
632,800
|
$55,491,000 | — | 31 Dec 2020 | |
| USS Investment Management Ltd |
13F
|
Company |
0.32%
|
623,186
|
$54,613,000 | — | 31 Dec 2020 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.32%
|
616,929
|
$54,099,000 | — | 31 Dec 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.3%
|
588,561
|
$51,611,000 | — | 31 Dec 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.3%
|
571,055
|
$50,076,000 | — | 31 Dec 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.28%
|
549,549
|
$48,190,000 | — | 31 Dec 2020 | |
| Capital International Investors |
13F
|
Company |
0.28%
|
546,661
|
$47,935,000 | — | 31 Dec 2020 |
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q1 2021
As of 31 Mar 2021,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
513 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
177,743,163 shares.
The largest 10 holders included
Capital Research Global Investors, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Inc., Dodge & Cox, BAKER BROS. ADVISORS LP, AMERIPRISE FINANCIAL INC, Clearbridge Investments, LLC, JANUS HENDERSON GROUP PLC, and STATE STREET CORP.
This page lists
516
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
519
Q1 2021 holders
513
Holder diff
-6
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.